In tendon and ligament repair research, the blend is used in combination protocols that aim to engage both cytoskeletal remodeling (TB-500's contribution) and angiogenic and growth-factor pathway activity (BPC-157's contribution) simultaneously
They are sometimes paired in research blends because the angiogenic plus cytoskeletal pathway combination covers complementary stages of the tissue-repair process
Thomas Ruiz, OB/GYN lead at MemorialCare Orange Coast Medical Center in Fountain Valley, CA, not involved in this study, expressed some caution about the findings, but also a measure of hope: Its too soon to extrapolate to humans
The preclinical research is extensive for a peptide: VEGF upregulation, nitric oxide signaling effects, gastric ulcer healing in animal models, intestinal anastomosis healing (Sikiric et al., Current Pharmaceutical Design, 2014)
Regena Peptides
Ensure you understand the plan at each stage: ask your doctor How long do we anticipate Ill need these? at the outset, and at follow-ups ask Are we going to recheck levels or try stopping soon? This will give you a sense of the expected duration